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Background
Effective delivery of treatments requires clear procedural details
of the essential elements of treatment. Hence the CONSORT
statement requests that trial reports provide ‘‘the interventions for
each group with sufficient details to allow replication, including
how and when they were actually administered’’. This detail is
often lacking, however, and systematic reviews of trials are further
complicated by variations in interventions. If a systematic review
finds that a class of interventions is effective, then the users of the
review will want to know: ‘‘Which version of the intervention
should I use?’’ Systematic reviews will usually examine several
trials with closely related, but rarely identical, interventions: the
details of the interventions will vary across trials. Even for
relatively simple clinical interventions, such as prescribing
antibiotics for acute sinusitis, the specific antibiotic, dose, duration,
and possibly frequency may vary. For more complex interventions,
such as strategies to implement clinical practice guidelines,
heterogeneity of intervention content and mode of delivery are
likely to be greater [1]. For example, a review of exercise for
patients with knee osteoarthritis found that it reduced pain and
improved function [2], but the studies used different types and
doses of exercise. A subsequent meta-analysis found that the best
programmes focused on quadriceps muscle strength and had
supervised exercise at least three times per week [3], which would
help guide the choice of exercise programme. However, to be
confident that the implementation of the findings in practice is
likely to be effective, the user also needs to know the types and
intensity of exercise(s), the duration of sessions, the schedule,
processes of tailoring or adjustment, and the context (for example,
physical setting and social influences) and modes of delivery (for
example, patient handouts or other materials needed by patients
trying to implement the intervention).
Whilst this can be a problem even in reports of individual trials [4,5],
having an adequate description of the intervention to be used poses an
even greater problem in reports of systematic reviews [6]. A review of
80 studies selected for summarizing in the journal Evidence-Based
Medicine because they were both valid and important for clinical
practice found that the intervention could be replicated by clinicians in
only half of the reports selected, and that this proportion was much
lower for interventions recommended in reports of systematic reviews
than for interventions recommended in individual studies [7]. The
problem is partly due to poor reporting (and complexity) of the
interventions within the included trials, but a further complication
results from variations in interventions across trials.
Current methods to guide the translation of evidence in systematic
reviews to the selection and prescription of a specific intervention
within a class of interventions are poorly developed and ignored by
most textbooks on systematic reviews and intervention design. The
three basic approaches are to (i) select the intervention used in an
individual trial; (ii) combine components of several trials—thereby
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Summary Points
N Effective delivery of treatments requires clear procedural
details of the essential elements of treatment. Hence, if a
systematic review finds that a class of interventions is
effective, then the users of the review will want to know:
‘‘Which version of the intervention should I use?’’
N Current methods to guide selection or synthesis from
the variations of a treatment used across trials in a
systematic review are poorly developed, and absent
from most instructions on systematic review methods.
N We identify three basic approaches: (i) single-trial-based
choice, where criteria such as feasibility, cost, effective-
ness, or familiarity guide which trial’s treatment to adopt;
(ii) common components hybrid, which extracts then
combines—based on frequency and importance—com-
ponents of several trials; and (iii) model-guided synthe-
sis, where a model of the mechanisms of effect is used to
code and assess the importance of components for the
version(s) recommended.
N Whichever method is used, we suggest review authors
provide an ‘‘intervention options table’’, which describes
the pros and cons of some intervention alternatives used
in an individual trial or set of trials.
N If clinicians and policymakers are to be expected to base
their practices on the results of systematic reviews in
practice, these three approaches will need to be more
widely adopted.
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creating a new, ‘‘synthetic’’ composite version of the intervention; or
(iii) pick an intervention or create a composite version guided by a
model of the mechanisms of the effect. Whichever method is used, we
suggest review authors provide an ‘‘intervention options table’’, which
describes the pros and cons of some intervention alternatives used in an
individual trial or derived from set of trials.
Choosing an intervention from a single trial—option (i)—is
simplest: it is more direct and requires little additional work, and it
avoids assumptions about the untested effects of a composite
intervention. However, the systematic review evidence of effect is
based not on any single trial, but on a synthesis of findings. Basing the
intervention on components from several, or all, trials—option (ii)—
has the appeal of using the components judged to be the best from all
the interventions—provided ‘‘the best’’ can be identified. While
attractive, this approach implies considerable additional work in
describing, comparing, and analysing the included trials, to identify
the potentially active components that are often insufficiently well
described [8]. Because of the heterogeneity of interventions, there
will only rarely be the statistical power to detect whether or not
components have contributed to the observed effects of interven-
tions. Guiding a synthesis by an understanding of the intervention’s
mechanisms—option (iii)—requires a theoretical understanding that
may not have guided the review or that may not be accepted by the
practitioners wishing to implement the review evidence.
This article considers possible methods for proceeding from the
evidence in systematic reviews to a choice of specific interventions
(medical treatments, public health interventions, health service
interventions, etc.). We have searched the published literature to
identify methods for addressing this challenge, checked the references
of papers describing approaches and methods, and conducted a
forward citation search from relevant articles identified. Our article is
a synthesis of existing and some newmethods, and describes the three
basic approaches and the advantages and limitations of each.
Options for Specifying Potential ‘‘Best Bets’’
among Interventions Considered in Systematic
Reviews
Though there is some overlap between the methods proposed,
the methods can be separated into three basic approaches: single-
trial-based choice, where an intervention category, and a specific
version of it, is selected based on several criteria such as the effect
size, practicality, cost, and relevance to a particular setting, from
among the tested interventions; common components hybrid,
which is a recombination approach where a composite (new)
intervention is constructed from the components of the interven-
tions tested in some of the studies included in the systematic
review; and model-guided synthesis, where the choice of a single or
combined intervention is guided by a theory of how the
interventions achieve their effects. Table 1 sets out some details
and differences of these three basic approaches.
Single-Trial-Based Choice—Choose among the Trial
Interventions
Single-trial-based choice is essential when the intervention is
considered ‘‘indivisible’’, for example, because of the necessity for
and/or interactions among components. For example, if each
study used a different variation of a device or surgical implant,
surgeons will need to select one implant rather than mix from the
set of implants used in similar studies.
To choose from among the tested interventions, criteria are
needed to make the basis for choice explicit. Such criteria may
include the size and certainty of the estimates of the effect, the
suspected or definite harms of the interventions, their applicability
in particular settings, and their costs, acceptability, or practicality.
Since no single intervention may be rated best on all these criteria,
reviewers should ideally set out a tabulation of the choices, similar
to the ‘‘buyer’s guides’’ common in consumer magazines, that is
perhaps best described as an intervention options table. Ideally the
table should include the option of ‘‘no intervention’’.
The apparent size of the effect requires particular consideration,
as small studies with similar ‘‘true’’ effects will have greater
dispersion, and hence some may appear to have larger effects by
chance. Users should treat such small study effects with
considerable caution. One potential method to reduce this
problem is to provide shrinkage estimates [9] that combine the
overall and individual estimates, with small studies receiving
greater shrinkage than larger ones.
In selecting a single study, there will be less certainty about the
effectiveness of the intervention, and sources of heterogeneity other
than the intervention, such as population, setting, or methodology,
should be considered. For example, consider the forest plot of studies
Table 1. Definitions and methods of the three basic approaches for intervention synthesis.
Attribute Single-Trial-Based Choice Common Components Hybrid Model-Guided Synthesis
Description Pick (or rank) the ‘‘best’’ intervention(s) from
those used across all trials
Develop a composite intervention based on
components of the interventions in all trials
Analyse interventions guided by a model
of the mechanisms of action
Processes Establish decision criteria, who is going to do the
ranking, and how consensus is to be achieved
List all components, code components from
trials, and select common components
Propose mechanism, code trial
interventions, and conduct subgroup
analyses or meta-regression
Output Ranked trial interventions, consensus data, and
selected single intervention
Composite intervention derived from all
interventions
A single study intervention or a composite
Assumptions and
requirements
Minimal assumption: at least some interventions
replicable; requires agreement about criteria for
‘‘best’’
Requires that sufficient details of
interventions can be obtained
Requires that sufficient details of
interventions can be obtained, and sufficient
diversity of studies to allow analysis such as
meta-regression
Limitations Intervention options confined to those tested
in the trials; depends on achieving consensus
Not possible for ‘‘indivisible’’ interventions;
composite intervention has not been
tested in any of the trials
Not possible for ‘‘indivisible’’ interventions;
depends on having sufficiently large dataset
for meta-regression, and on the validity of
the chosen theoretical mechanism
Effort Minimal; consensus exercise and analysis Several person-months of work Several person-months of work
doi:10.1371/journal.pmed.1001690.t001
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assessing the effects of using pedometers to increase physical activity
shown in Figure 1. Many users may be uncomfortable basing their
intervention on trials 1 or 4 (in which the intervention apparently had
a more modest effect than in the other studies, and did not yield
statistically significant estimates of effect). Others may also not wish to
use the interventions from studies 2 or 5 (as they yielded point
estimates of effect that were less than the average estimate of effect,
and the confidence interval in study 5 includes no difference).
Further, if the interventions in all trials were similarly difficult to
implement, but the interventions in studies 3, 6, and 8 were twice the
cost of that in study 7, then the intervention from study 7 might be the
preferred choice. However, the choice (and effect) may also vary with
settings and populations, and if one study was performed in a
population and setting most like that in which an intervention will be
implemented, basing the intervention on this study may be the
preferred choice.
A variant of the above process is to group the interventions that
are sufficiently ‘‘similar’’ (across many possible dimensions) to be
considered the same intervention. Provided this was specified a
priori, the effect sizes might then be taken from a subgroup
analysis based on these studies, rather than from the individual
studies. An example is a systematic review of ‘‘autoinflation’’ for
treating glue ear in children [10]: we asked an ENT surgeon, blind
to the results of each study, to group together similar devices for
autoinflation. These groups were then used for subgroup analysis
(no differential effects were detected). This example also illustrates
the need for a mix of expertise in the review group, including
expertise in the disease and intervention domains.
Common Components Hybrid—Recombination of
Selected Components
If the interventions have multiple components, it may be
possible to judge which components are likely to be necessary
and/or effective and use these to propose a composite interven-
tion. For example, Langhorne and Pollock [11] used all trials of
specialized ‘‘stroke unit’’ care to identify the components judged to
be most important, then surveyed the lead authors of those trials
(who were involved in an individual patient data meta-analysis) to
find out which components they planned to use and which they
had actually used, hence deriving from their responses a proposed
composite intervention. However, this composite intervention was
a new intervention, which had not been formally tested; hence,
caution is required in recommending and applying it. Ideally, the
proposed composite intervention should be evaluated in a further
trial of adequate statistical power.
Separation of the intervention into ‘‘components’’ is not
straightforward. Depending on the type of intervention, the
components may include the mode of delivery and materials, the
intensity or dose used, the sequencing or scheduling of compo-
nents, and so on. A number of checklists have been developed for
different types of interventions to assist with this deconstruction
[12,13], and a generic checklist was recently developed [14], but
further research in this area is needed.
After the deconstruction phase, the approach to the recombi-
nation of components will depend on how independent or
dependent those components are and the quality and quantity of
evidence of their effectiveness on their own, in combinations with
each other, and with other intervention components. For example,
many of the stroke unit trials included not only components of
stroke management and measurement, but also education for staff
in undertaking these components, and all three (staff education,
measures, and management) may be needed for some elements to
be effective.
If the interventions separate readily into multiple components
believed to act independently of each other, then finding a
composite intervention including these components is reasonable.
The possible composite interventions range from those compo-
nents common to all of the (effective) interventions, to a
Figure 1. Trials of pedometer interventions to increase physical activity [18]: table of intervention elements of studies with forest
plot of effect.
doi:10.1371/journal.pmed.1001690.g001
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composite intervention that includes all of the components
contained in any of the interventions assessed. For example,
based on the systematic review of trials of stroke units described
above, Langhorne and Pollock proceeded as follows. (i) They
selected trials where the intervention was beneficial (in their
method, the point estimate of the effect needed to favour the
intervention, but did not need to be statistically significant). (ii)
They identified key components from the included trials,
protocols, and intervention manuals, then surveyed the authors
of the trials selected to ask for additional components. (iii) They
compiled the full list, then resurveyed the authors to ask which
components they had actually used (preferably based on study
data, but if that was not possible, then based on trial author’s
recall). (iv) They derived a composite intervention based on those
components used in at least half of the trials in which the point
estimate suggested a beneficial effect.
The above recombination process assumes that the more
commonly used components are the most important ones, which
may or may not be true. Clearly, it would be better to identify the
minimal set of active components necessary to achieve any
beneficial effects. One method of identifying the ‘‘active ingredi-
ents’’ of interventions [5] is to systematically specify the
components of both the intervention and the control comparison
conditions, using standardized taxonomies, and then use meta-
regression to seek effects undetected by more conventional
evidence synthesis methods [15,16]. Sufficient numbers of studies
and intervention data will not always be available or obtainable to
allow this approach; hence, a pragmatic alternative is needed.
Furthermore, if the initial set of studies is limited to those
interventions that are apparently more effective, there is a loss of
information on which to base subgroup analysis.
If there are sufficient independent components and sufficient
trials (and intervention details), then several techniques, including
subgroup analysis and/or meta-regression, may help to identify
effective components. For example, Sherrington and colleagues
[17] identified ten effective components of the interventions in 44
trials of exercise programmes to reduce falls. A meta-regression
(which included quality and other non-intervention features in
addition to the intervention features) found that programmes were
more effective if they used a higher total dose of aerobic exercise
and challenging balance exercises, and did not include a walking
programme. That conclusion is helpful, but still requires some
implementable specification of these effective components, as well
as any common components.
Similarly, the systematic review (Figure 1) of pedometers (a
multi-component intervention of which the device is only one part)
included several subgroup analyses of different components of the
interventions [18]. The authors concluded: ‘‘[H]aving a step goal
was the key predictor of increased physical activity (P = .001).
Indeed, there were no statistically significant improvements in
physical activity in the 3 studies that did not include a step goal.’’
They also found that a step diary and non-workplace settings
appeared to strengthen the effect, but there was no statistically
significant effect associated with the brand of pedometer.
However, this still leaves several different versions of the
intervention (with step goals and diaries) to choose from.
For some interventions, the multiple components may simply be
a collection of independent components with no dependence or
interaction, such as balance exercises and home modification (floor
repairs, grab rails, etc.) to prevent falls. However, when the
components are dependent on or interact with one another, the
composite methods outlined above may be neither feasible nor
reasonable. As an illustration, imagine three trials of interventions
to eradicate Helicobacter pylori infection using the same two
antibiotics in combination but a different proton pump inhibitor in
each—omeprazole, pantoprazole, or lansoprazole. Unless the
reviewers recognized that these three ‘‘-azoles’’ were all drugs
within the one class (proton pump inhibitors), rather than
mistaking them as three different components, we might
incorrectly conclude that, since antibiotics were the only compo-
nent used in more than 50% of studies, the proton pump inhibitor
was unnecessary. However, it may be possible to draw boundaries
around some collections of components, and thereby create
independent components again. This example suggests it may be
important for the recombination process to be guided by an
understanding of what role the components of an intervention
play—that is, a theory predicting or explaining the intervention’s
action.
Model-Guided Synthesis
A limitation of the common components hybrid approach is
that we are restricted to the components used in the included
trials. As the simplest example, suppose the drug doses used in the
trials were all either 50 mg or 200 mg daily, and these appeared to
have equivalent effects on the primary outcome. The common
components hybrid approach would require using either 50 mg or
200 mg, but not 100 mg. However, pharmacological reasoning
would suggest that 100 mg is likely to have an intermediate effect
and but may have fewer or less troublesome adverse effects than
the 200-mg dose. The analysis of a dose–response relationship is
also possible for non-drug interventions, but requires that
components of the interventions can be ranked by ‘‘dose’’. For
example, exercise for patients with heart failure, which improves
symptoms and quality of life, would require an analysis of the
duration or number of sessions, or the intensity of each. But this
also requires some means of judging equivalence, such as
achieving a particular percent of maximum heart rate. A dose–
response analysis may help clarify which version of the interven-
tion to use, and whether additional gains are worth the extra
effort, cost, or side effects.
Assigning a ‘‘dose’’ requires identification of a central component
(or components) of the intervention, and hence some understanding
of its mechanism of action. Sometimes a dose–response analysis may
be done directly by doing subgroup analyses on the different doses.
However, statistically confident identification of differential effects
of different doses requires a substantial amount of data in the strata
being compared, and this may not be available.
More complex models of the mechanism of action might be
used to guide the analysis of the components of the intervention. A
model-guided analysis goes beyond recombination of components,
and tries to identify the mechanism of action and the key
components needed for the intervention to be effective. In a re-
analysis of a Cochrane review [19] of audit and feedback for
changing clinician behaviour, Gardner et al. [16] used control
theory to analyse the effects of the interventions used. The control
theory model (Figure 2) suggested that, to be effective, feedback
should be accompanied by comparison with a behavioural target
and by action plans. The authors coded all the trials to assess the
extent to which the intervention incorporated these behaviour
change techniques. The same analytic strategy was used in the
updated Cochrane review [19], which had sufficient statistical
power to test the theoretical prediction. A meta-regression based
on the coded components of control theory found that interven-
tions including a target and action plans were more effective than
those including only feedback.
When this analysis of the model is complete, its confirmed
elements may be used as a guide in selecting the most desirable
version of the intervention (Figure 3). The precise details from the
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studies are still important as exemplars and options, but the
theoretical understanding allows greater choice and adaptation.
A key limitation of the model-guided synthesis approach is the
need for multiple trials with well-described interventions that
provide sufficient variation and statistical power for subgroup
analyses or meta-regression. Indeed, a danger is that an effective
component is used by interventions in all trials, and hence the lack
of variation between trials in this respect would mean that its effect
would not be identified in the meta-regression. A further limitation
is that meta-regression can be confounded by other study features,
such as the population studied, the context, or the methods used
[20], for which a meta-analysis based on individual patient data
would be desirable but considerably increases the workload.
A supplementary approach to the model-analysis and meta-
regression outlined above would be to also use an ‘‘accepted’’
surrogate outcome, rather than just the primary clinical outcome.
For example, in an analysis of the effect of statins on cardiovascular
disease, the authors showed not only that statins were effective
overall, but also, using meta-regression [21], that the relationship
between degree of cholesterol reduction and mortality reduction
was approximately log-linear. The recommendation for interven-
tion can thus be based on the marginal gain from increasing the
degree of cholesterol reduction achieved by different drugs and
doses. However, assumptions about the linearity of the dose–
response relationship would need to be checked in each review.
Discussion
Few systematic reviews currently provide much guidance on the
specific forms of an intervention that should be used in different
circumstances [7]. This has been partly due to a lack of awareness
of the information needs of users of systematic reviews—clinicians,
patients, policymakers—and partly a lack of explicit methods for
analysing, synthesizing, and extrapolating from interventions
grouped in the reviews. While the methods described in this
article warrant further methodological development and testing,
currently available methods should be more widely applied.
The choice of method for informing how best to translate review
findings into evidence-based practice will depend on the types of
interventions included, the nature of the data reviewed, and the
resources available to reviewers. The appropriateness of different
methods will depend on whether the interventions are ‘‘indivisible’’,
have single or multiple components, and can be ranked by intensity;
whether and how the components interact; and the amount of data
available for analysis. The composite methods for multi-component
interventions require considerable extra work—Langhorne and
Pollock’s method required at least two rounds of surveys—which
may not always be feasible or necessary. However, the simpler
single-trial-based choice methods, particularly the presentation of
an intervention options table, should always be possible, and can be
done even if some of the interventions have incomplete or
inadequate descriptions. In most cases, a method to guide the
selection of an intervention could be reported in the review.
Given the different needs of different users in different countries,
the intervention options table should provide a summary of the
usable and feasible interventions in the review, with information
on the criteria on which users would base their choice. Such a
table could include both individual study interventions and
synthesized interventions, providing users with a wider choice.
Some interventions may also reasonably be omitted, for example,
if they are insufficiently well described or contain inaccessible
products. These decisions will require some judgement. For
example, a recent NICE guideline for social anxiety disorder [22]
recommended use of either of two ‘‘manualized’’ trial-based
treatments, but did not recommend a synthetic approach because
of uncertainties about interactions between elements [22].
There are several current barriers to applying these methods.
The most problematic is inadequate description of interventions in
the reports of primary studies [23]. Further work by authors,
editors, and methodologists is required to improve the published
descriptions available to reviewers and clinicians [6], in particular
improved public access to protocols and protocol materials.
However, we have demonstrated previously [8] that further details
are often available from authors or other sources, and poor
Figure 2. Example of the control theory model used for coding interventions in a review of audit and feedback studies by Gardner
et al. [16].
doi:10.1371/journal.pmed.1001690.g002
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published descriptions cannot be used to justify ignoring this
important aspect of systematic reviews [24].
Poor description applies not only to the content of interventions,
but also to their mode of delivery, contextual features, and
underlying theory. Several checklists have been developed to assist
authors in publishing better descriptions of interventions, for
example, for public health interventions [25], behavioural
interventions [26], and non-pharmacological interventions more
generally [13]. However, evaluations are of interventions that have
been delivered and are most likely not the exact interventions that
were planned. These checklists can be used to both specify
planned and assess actual interventions. When this was done in
relation to interventions to increase physical activity in those at risk
of type 2 diabetes, it was found that 42% of the techniques
specified in the intervention manual were delivered in practice
[27]. This is a key issue for interpreting the results of systematic
reviews since variation in adherence is likely to lead to variation in
effect size [28].
In addition to the additional work involved, a central
limitation of the common components hybrid and model-guided
synthesis approaches is that the new ‘‘synthetic’’ composite
intervention has not been tested formally in a controlled trial. If
that leads to sufficient doubt about efficacy, then one way
forward is to recommend a single-trial-based choice as the
control group in a new comparison with the common compo-
nents hybrid composite. Since there may be several uncertain
components, researchers should consider factorial designs or
phased adaptive designs [29].
Additional resources containing further details about interventions
may support clinicians and policymakers in implementing the results
of systematic reviews where detailed description of the intervention is
lacking or where there is uncertainty based on heterogeneity within a
category of included studies. For example, the Handbook of Non-
Drug Interventions (HANDI; http://www.racgp.org.au/handi) aims
to document details about non-pharmacological interventions to
facilitate replication. Written by a panel of practitioners, with peer
review from an expert in the intervention, resources such as this, and
some clinical practice guidelines, may enable more formal approaches
to choosing and describing an intervention from a systematic review.
While further work is warranted on all three of the basic
approaches described here, the basic techniques are sufficiently
clear for use in current systematic reviewing practice. As those
doing systematic reviews will have done much of the work, we
think they are in the best position to apply these methods, but
recognize that the workload may be such that a separate report is
required. However, as a minimum, those preparing systematic
reviews could provide a table describing the elements of each
version of the intervention studied. This table should also highlight
differences between trials’ interventions, to allow readers to judge
more readily which might be most appropriate in their circum-
Figure 3. The steps from systematic review to a specific version of an intervention, showing the three basic approaches.
doi:10.1371/journal.pmed.1001690.g003
PLOS Medicine | www.plosmedicine.org 6 August 2014 | Volume 11 | Issue 8 | e1001690
stances. If clinicians, patients, and policymakers are to be expected
to apply the results of systematic reviews in practice, these
approaches will need to be more widely adopted.
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